Want to see EPC full AI Analyst Report?
Top Page
Edgewell Personal Care
(NYSE:EPC)
Select Model
Select Model
Rating:58Neutral
Price Target:
$30.00
▲(8.58% Upside)
Action:Reiterated
Date:08/06/26
The score is held back primarily by deteriorated TTM profitability (net loss and sharply lower operating margins) and still-reduced free cash flow versus prior years. These are partly offset by a constructive technical trend, positive cash generation and manageable balance-sheet leverage, and a mixed-but-stabilizing earnings outlook with reiterated guidance and expected Q4 margin improvement.
Positive Factors
Brand Momentum
Sustained strong growth at priority brands (Cremo, Hawaiian Tropic, Billie) signals durable brand equity and successful retailer penetration. Repeated double-digit gains and share capture indicate scalable revenue drivers and higher customer loyalty that support predictable repeat purchases and long-term shelf relevance.
Negative Factors
Profitability Deterioration
A swing to a sizeable net loss and materially compressed operating margins signals structural profit recovery is needed. Even with stable gross margin, elevated operating costs and one-time charges reduce return generation and prolong the time required to reinstate consistent reinvestment capacity and ROE.
Read all positive and negative factors
Positive Factors
Negative Factors
Brand Momentum
Sustained strong growth at priority brands (Cremo, Hawaiian Tropic, Billie) signals durable brand equity and successful retailer penetration. Repeated double-digit gains and share capture indicate scalable revenue drivers and higher customer loyalty that support predictable repeat purchases and long-term shelf relevance.
Read all positive factors
Edgewell Personal Care Key Performance Indicators (KPIs)
Any
Operating Income by Segment
Reports operating profit for each segment, revealing which businesses generate sustainable profits after costs, which dilute margins, and where management should prioritize cost control or capital allocation to improve overall profitability.
Reports operating profit for each segment, revealing which businesses generate sustainable profits after costs, which dilute margins, and where management should prioritize cost control or capital allocation to improve overall profitability.
Data provided by:
The Fly
The FlyEdgewell Personal Care (EPC) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.31B
Dividend Yield2.11%
Average Volume (3M)800.44K
Price to Earnings (P/E)―
Beta (1Y)0.36
Revenue Growth-7.00%
EPS Growth-246.78%
CountryUS
Employees6,700
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-2.00
Shares Outstanding46,088,917
10 Day Avg. Volume775,628
30 Day Avg. Volume800,439
Financial Highlights & Ratios
PEG Ratio-0.52
Price to Book (P/B)0.62
Price to Sales (P/S)0.43
P/FCF Ratio23.36
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$31.67Price Target Upside14.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)1.93
Revenue Forecast (FY)$1.99B
Edgewell Personal Care Business Overview & Revenue Model
Company Description
Edgewell Personal Care Company, along with its associated businesses, is a global producer and distributor of a diverse range of personal care items. The company organizes its operations into three main divisions: Wet Shave, Sun and Skin Care, and...
How the Company Makes Money
Edgewell makes money by selling branded personal care products to retailers and distributors (and, in some cases, directly to consumers via e-commerce). Its revenue is generated mainly from product sales across its core categories: (1) Wet shave: ...
Edgewell Personal Care Earnings Call Summary
Earnings Call Date:Aug 05, 2026
(Q3-2026)
| % Change Since: |
Next Earnings Date:Nov 05, 2026
Earnings Call Sentiment Neutral
The call presented a mixed but constructive picture: management highlighted a return to organic sales growth, clear North American improvements, strong brand momentum across marquee brands (Cremo, Hawaiian Tropic, Billie), realized productivity savings, healthy Q3 operating cash flow, and an unchanged mid-point full-year outlook. Offsetting these positives were international weakness driven largely by transitory private-label supply disruptions, margin pressure from mix/inflation/promotions, lower GAAP EPS and reduced operating income versus prior year, and near-term elevated leverage associated with divestiture timing. Management emphasized that many headwinds are transitory, progress on the manufacturing consolidation is underway, and Q4 gross margin expansion is expected, but growth guidance for the year remains modest.Positive Updates
Return to Organic Net Sales Growth
Organic net sales increased 1.1% in Q3, marking a return to growth after prior periods of pressure and providing momentum into the back half of fiscal '26.
Negative Updates
International Organic Sales Decline
International organic net sales declined 1.4% in Q3, negatively impacted by the Middle East conflict, private label supply disruptions, and a weaker-than-anticipated start to the sun season in Europe and Latin America.
Read all updates
Q3-2026 Updates
Positive
Negative
Return to Organic Net Sales Growth
Organic net sales increased 1.1% in Q3, marking a return to growth after prior periods of pressure and providing momentum into the back half of fiscal '26.
Read all positive updates
Company Guidance
Edgewell reiterated and narrowed its fiscal 2026 guidance: organic net sales flat to +50 bps; adjusted EPS $1.80–$2.00; adjusted EBITDA $250–$260M; adjusted free cash flow (ex‑Feminine Care timing) ~$80–$110M; and adjusted net debt leverage to finish the year at ~3.3–3.4x (including an estimated 0.3–0.4x temporary negative turn from the Fem Care divestiture). Management also expects stronger Q4 (with mid‑single‑digit international growth and continued North America strength), material gross‑margin expansion in Q4 driven by productivity, cycling of one‑time items and favorable FX (though the full‑year gross‑margin rate was modestly reduced), and reiterated planned A&P investment levels; for context Q3 results included organic +1.1%, North America +3%, adjusted EBITDA $78.9M, adjusted EPS $0.72 (GAAP EPS $0.26), ~200 bps of productivity savings, A&P at 14.6% of sales, and operating cash flow of about $119M in Q3.Edgewell Personal Care Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
56
Neutral
Cash Flow
52
Neutral
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.05B | 2.22B | 2.25B | 2.25B | 2.17B | 2.09B |
| Gross Profit | 837.70M | 924.90M | 955.70M | 940.80M | 880.50M | 951.20M |
| EBITDA | 55.00M | 185.60M | 285.40M | 317.60M | 285.40M | 302.10M |
| Net Income | -93.20M | 25.40M | 98.60M | 114.70M | 99.50M | 117.80M |
Balance Sheet | ||||||
| Total Assets | 3.54B | 3.76B | 3.73B | 3.74B | 3.71B | 3.67B |
| Cash, Cash Equivalents and Short-Term Investments | 397.10M | 225.70M | 209.10M | 216.40M | 188.70M | 479.20M |
| Total Debt | 1.28B | 1.54B | 1.39B | 1.45B | 1.46B | 1.32B |
| Total Liabilities | 2.08B | 2.20B | 2.15B | 2.20B | 2.25B | 2.09B |
| Stockholders Equity | 1.46B | 1.55B | 1.58B | 1.54B | 1.47B | 1.58B |
Cash Flow | ||||||
| Free Cash Flow | 52.40M | 41.40M | 174.50M | 166.60M | 45.60M | 172.20M |
| Operating Cash Flow | 121.20M | 118.40M | 231.00M | 216.10M | 102.00M | 229.00M |
| Investing Cash Flow | 273.40M | -72.90M | -62.40M | -50.50M | -355.40M | -48.70M |
| Financing Cash Flow | -193.80M | -30.00M | -179.40M | -146.50M | -17.60M | -65.40M |
Edgewell Personal Care Technical Analysis
Positive
27.63
Price Trends
26.00
Positive
23.19
Positive
20.97
Positive
Market Momentum
0.66
Positive
56.90
Neutral
54.83
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EPC, the sentiment is Positive. The current price of 27.63 is below the 20-day moving average (MA) of 28.12, above the 50-day MA of 26.00, and above the 200-day MA of 20.97, indicating a bullish trend. The MACD of 0.66 indicates Positive momentum. The RSI at 56.90 is Neutral, neither overbought nor oversold. The STOCH value of 54.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EPC.
Edgewell Personal Care Risk Analysis
Edgewell Personal Care disclosed 28 risk factors in its most recent earnings report. Edgewell Personal Care reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Edgewell Personal Care Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $24.03B | 32.47 | 17.78% | 1.23% | 2.69% | 46.04% | |
70 Outperform | $2.09B | 27.01 | 4.22% | 2.12% | 0.82% | 23.29% | |
64 Neutral | $36.82B | 18.77 | 143.64% | 4.63% | -12.19% | -19.22% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | $1.31B | -14.21 | -6.27% | 2.17% | -7.00% | -246.78% | |
56 Neutral | $2.42B | -4.61 | -15.12% | ― | -3.57% | -32.30% | |
54 Neutral | $2.63B | -11.81 | -8.95% | 5.51% | -2.04% | 9.26% |
* Consumer Defensive Sector Average
EPC
Edgewell Personal Care
28.42
6.15
27.63%
CHD
Church & Dwight
101.30
10.00
10.95%
KMB
Kimberly Clark
110.39
-16.34
-12.90%
NWL
Newell Brands
6.24
1.13
22.19%
SPB
Spectrum Brands Holdings
89.93
34.60
62.54%
COTY
Coty
2.85
-2.07
-42.07%
Edgewell Personal Care Corporate Events
Business Operations and StrategyExecutive/Board Changes
Edgewell Names New Chief Supply Chain Officer
Neutral
May 26, 2026
On May 20, 2026, Edgewell Personal Care Company announced that Chief Supply Chain Officer Paul R. Hibbert will leave his role effective June 1, 2026, and that he will receive payments and benefits under the company’s executive severance plan...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.